If you take prescription drugs — and most Medicare beneficiaries do — 2026 is one of the most consequential years in Part D history to pay close attention to your coverage. The Inflation Reduction Act's $2,000 annual out-of-pocket cap on covered Part D drugs took full effect this year, fundamentally changing how the most expensive drug plans compare to more modest ones. That single policy change has reshuffled the rankings of which plans deliver the best value, and it means beneficiaries who stayed in the same plan for years without reviewing it may now be overpaying or underprotected.
The national base beneficiary premium for standalone Part D plans in 2026 is $36.78 per month, according to the Centers for Medicare & Medicaid Services. But that number is almost meaningless on its own — actual premiums vary enormously by plan and by region. Some standalone Prescription Drug Plans (PDPs) carry monthly premiums under $10, while others exceed $100. The difference often comes down to how broadly a plan covers brand-name drugs, which pharmacy networks it uses, and how aggressively it negotiates with drug manufacturers. Paying a higher premium does not automatically mean better coverage for your specific medications.
The $2,000 out-of-pocket cap is the headline change, but understanding what it actually covers matters. The cap applies to drugs on your plan's formulary — the official list of covered medications. If your drug is not on the formulary, costs for that drug do not count toward the cap. This makes formulary review more critical than ever. Before selecting or sticking with a plan, you should run your specific drug list through Medicare's Plan Finder tool at Medicare.gov, which allows you to enter every medication you take and compare your estimated annual costs — including premiums, deductibles, and copays — across every plan available in your ZIP code. This tool is free, updated annually, and is the single most reliable way to find your lowest-cost option.
Also new in 2026 is the Medicare Prescription Payment Plan, sometimes called the smoothing program. This voluntary option allows beneficiaries to spread their out-of-pocket drug costs across monthly installments throughout the year rather than paying large lump sums when filling expensive prescriptions early in the year. For someone who takes a specialty drug that costs thousands of dollars per fill, this can prevent a devastating financial hit in January or February. Enrollment in the payment plan is handled through your Part D plan directly — you must opt in each year, and it does not reduce what you owe, only when you pay it.
When evaluating specific plan providers for 2026, the major national carriers offering standalone Part D plans include UnitedHealthcare (AARP-branded), Humana, CVS Health (Aetna/SilverScript), Cigna-Evernorth, and Wellcare. Each operates multiple plan tiers at different price points. Humana and Wellcare have historically offered some of the lowest-premium options in many regions, though low premiums sometimes come with higher deductibles — up to the 2026 standard deductible of $590 — or narrower pharmacy networks that exclude preferred pricing at certain chains. UnitedHealthcare's AARP MedicareRx plans tend to score well on member satisfaction surveys and often include preferred pricing at a wide range of pharmacies, but premiums are typically higher than budget alternatives.
Pharmacy network structure is one of the most overlooked factors in Part D plan selection. Most plans now use a tiered pharmacy network with preferred and non-preferred pharmacies. Using a preferred pharmacy — often a specific chain like Walgreens, CVS, Walmart, or a mail-order service — can reduce your copays substantially compared to using an out-of-network or non-preferred pharmacy. Some plans offer $0 copays on Tier 1 generic drugs at preferred pharmacies, while the same drug at a non-preferred pharmacy might cost $10 to $15 per fill. Over a year of monthly fills, that difference adds up to $120 to $180 on a single drug. If you have multiple prescriptions, the savings from choosing a plan aligned with your preferred pharmacy can easily exceed $500 annually.
For beneficiaries enrolled in Medicare Advantage (Part C) plans, drug coverage typically comes bundled into the MA plan rather than through a standalone PDP. In 2026, the same $2,000 out-of-pocket cap applies to the drug portion of MA-PD plans. However, MA plans also have their own medical out-of-pocket maximum — which is separate from the drug cap. Comparing MA-PD plans requires looking at both limits simultaneously. A plan with a low drug premium but a high medical out-of-pocket maximum may not be the best deal for someone managing both chronic conditions and expensive medications.
Low-income beneficiaries should know that the Extra Help program — also called the Low Income Subsidy — was significantly expanded under the Inflation Reduction Act. In 2026, beneficiaries with incomes up to 150% of the federal poverty level (roughly $21,870 for an individual) may qualify for full Extra Help, which eliminates the Part D deductible and caps copays at a few dollars per prescription. Partial Extra Help is available at higher income levels. If you are not sure whether you qualify, you can apply through Social Security at ssa.gov or through your State Health Insurance Assistance Program (SHIP) counselor at no cost. SHIP counselors are trained volunteers who can walk you through plan comparisons without any sales pressure or conflict of interest.
The Annual Enrollment Period for 2027 coverage will run October 15 through December 7, 2026. If you missed the window to change your Part D plan for this year, you may still qualify for a Special Enrollment Period if you experience a qualifying life event — such as moving to a new address, losing other drug coverage, or qualifying for Extra Help. The Open Enrollment Period from January 1 through March 31 also allows Medicare Advantage enrollees to switch plans or drop back to Original Medicare with a standalone PDP, though standalone PDP-to-PDP switches are not permitted during OEP. Knowing which window applies to your situation can mean the difference between being locked into a costly plan for the year or finding a better fit.
The bottom line for 2026 is that the rules of Part D have changed enough that a plan that was right for you in 2024 or 2025 may no longer be your best option. The $2,000 cap, the new payment smoothing option, and shifting premium structures across major carriers all create new winners and losers depending on your drug list. Spending 30 minutes on Medicare's Plan Finder — or calling 1-800-MEDICARE — before the next enrollment period could realistically save you hundreds of dollars over the course of the year.